Article: Nicotinamide Riboside Improves Mitochondrial Function and Survival Post-Heart Attack: Preclinical Findings

PrevNext
Cardiovascular Disease Cardiovascular Health Mitochondrial Health Preclinical

Nicotinamide Riboside Improves Mitochondrial Function and Survival Post-Heart Attack: Preclinical Findings

Synopsis

Myocardial infarction (MI), or heart attack, is a leading cause of death, and reduced NAD+ levels in the heart can worsen damage after MI. This study tested whether nicotinamide riboside (NR), an NAD+ precursor, could protect the heart in mice after MI. MI caused a sharp drop in heart NAD+ levels, mitochondrial dysfunction, and lower survival. Daily NR treatment restored NAD+ levels, improved mitochondrial function, reduced harmful inflammation, and increased survival from 61% to 92%. These results suggest that NR supplementation may help protect the heart and improve outcomes after myocardial infarction.

Journal

Cardiovascular Drugs and Therapy

Share

Read more

Healthy Aging & Longevity

Nicotinamide Riboside Improves Mitochondrial Health in Werner Syndrome: Preclinical Findings

SynopsisWerner syndrome (WS) is a rare accelerated aging disease caused by mutations in the WRN gene, leading to metabolic problems and premature cell aging. This study found that loss of WRN incre...

Read more
Mitochondrial Health

Nicotinamide Riboside Improves Mitochondrial Function and Exercise Ability in ANT1-Deficiency: Preclinical Findings

SynopsisMitochondrial disorders are often characterized by muscle weakness and fatigue. Mutations in the heart-muscle adenine nucleotide translocator isoform 1 (ANT1) (or ANT1-deficiency) of both h...

Read more